BECTON DICKINSON & CO — Director's Dealing 2026

Jan 16, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2026-01-15

Reporting Person: Garrison Michael David (EVP & Pres Med.Essntl&BioPharm)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-15	Common Stock	M	3054	$167.91	Acquired	16159	Direct
2026-01-15	Common Stock	D	2454	$209	Disposed	13705	Direct
2026-01-15	Common Stock	S	600	$209	Disposed	13105	Direct
2026-01-15	Common Stock	S	1010	$206.54	Disposed	12095	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-15	Stock Appreciation Rights	$167.91	M	3054	Disposed	2026-11-26	Common Stock (3054)	Direct

Footnotes

F1: The stock appreciation rights vested in four annual installments beginning one year from the grant date.